I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Fuxing Lou
45
results:
Search for persons
X
Format
Online (45)
Mediatypes
Articles (Online) (20)
OpenAccess-fulltext (25)
Sorted by: Relevance
Sorted by: Year
?
1
Pharmacological Activity of Cepharanthine:
Liu, Ke
;
Hong, Bixia
;
Wang, Shuqi
...
Molecules. 28 (2023) 13 - p. 5019 , 2023
Link:
https://doi.org/10.3390/..
?
2
Efficient disinfection of SARS-CoV-2-like coronavirus, pseu..:
Qin, Hongbo
;
Qiu, Hengju
;
He, Shi-Ting
...
Journal of Hazardous Materials. 430 (2022) - p. 128414 , 2022
Link:
https://doi.org/10.1016/..
?
3
Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteri..:
Xu, Ailan
;
Hong, Bixia
;
Lou, Fuxing
...
MedComm. 3 (2022) 3 - p. , 2022
Link:
https://doi.org/10.1002/..
?
4
2'-Fucosyllactose Inhibits Coxsackievirus Class A Type 9 In..:
Lou, Fuxing
;
Hu, Ruolan
;
Chen, Yangzhen
...
International Journal of Molecular Sciences. 23 (2022) 22 - p. 13727 , 2022
Link:
https://doi.org/10.3390/..
?
5
Molnupiravir and Its Antiviral Activity Against COVID-19:
Tian, Lili
;
Pang, Zehan
;
Li, Maochen
...
Frontiers in Immunology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
6
Bovine lactoferrin inhibits SARS‐CoV‐2 and SARS‐CoV‐1 by ta..:
He, Shi‐ting
;
Qin, Hongbo
;
Guan, Lin
...
Journal of Medical Virology. 95 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1002/..
?
7
Overview of Breastfeeding Under COVID-19 Pandemic:
Pang, Zehan
;
Hu, Ruolan
;
Tian, Lili
...
Frontiers in Immunology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
8
SARS-CoV-2 variant Omicron: currently the most complete "es..:
Li, Maochen
;
Lou, Fuxing
;
Fan, Huahao
Signal Transduction and Targeted Therapy. 7 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
9
The emergence of powerful oral anti-COVID-19 drugs in the p..:
Fan, Huahao
;
Lou, Fuxing
;
Fan, Junfen
..
The Lancet Microbe. 3 (2022) 2 - p. e91 , 2022
Link:
https://doi.org/10.1016/..
?
10
The Benefits of Breastfeeding Still Outweigh the Risks of C..:
Lou, Fuxing
;
Qin, Hongbo
;
He, Shiting
...
Frontiers in Medicine. 8 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
11
Understanding the Secret of SARS-CoV-2 Variants of Concern/..:
Lou, Fuxing
;
Li, Maochen
;
Pang, Zehan
...
Frontiers in Immunology. 12 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
12
SARS-CoV-2 Variants of Concern Delta: a great challenge to ..:
Li, Maochen
;
Lou, Fuxing
;
Fan, Huahao
Signal Transduction and Targeted Therapy. 6 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1038/..
?
13
SARS-CoV-2 variants: a new challenge to convalescent serum ..:
Li, Maochen
;
Lou, Fuxing
;
Fan, Huahao
Signal Transduction and Targeted Therapy. 6 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1038/..
?
14
Pharmacological Activity of Cepharanthine:
Ke Liu
;
Bixia Hong
;
Shuqi Wang
...
https://www.mdpi.com/1420-3049/28/13/5019. , 2023
Link:
https://doi.org/10.3390/..
?
15
Pharmacological Activity of Cepharanthine:
Ke Liu
;
Bixia Hong
;
Shuqi Wang
...
Medicinal Chemistry. , 2023
Link:
https://doi.org/10.3390/..
1-15